These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Unsupported off-label chemotherapy in metastatic colon cancer. de Souza JA; Polite B; Perkins M; Meropol NJ; Ratain MJ; Newcomer LN; Alexander GC BMC Health Serv Res; 2012 Dec; 12():481. PubMed ID: 23272659 [TBL] [Abstract][Full Text] [Related]
3. Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications. Gray SW; Armstrong K; Demichele A; Schwartz JS; Hornik RC Cancer; 2009 Apr; 115(7):1424-34. PubMed ID: 19235785 [TBL] [Abstract][Full Text] [Related]
4. Antitumor activity in metastatic disease does not predict efficacy in the adjuvant setting. Segal NH; Saltz LB JAMA; 2012 Apr; 307(13):1431-2. PubMed ID: 22474207 [No Abstract] [Full Text] [Related]
5. Orexins in apoptosis: a dual regulatory role. Cavalu S; Saber S; Hamad RS; Abdel-Reheim MA; Elmorsy EA; Youssef ME Front Cell Neurosci; 2024; 18():1336145. PubMed ID: 38699177 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of sorafenib and plant-derived phytochemicals in human colorectal cancer cells. Bahman A; Abaza MS; Khoushaish S; Al-Attiyah RJ BMC Complement Med Ther; 2023 Jun; 23(1):210. PubMed ID: 37365571 [TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive carriers for oral drug delivery. Kumar R; Islam T; Nurunnabi M J Control Release; 2022 Nov; 351():504-559. PubMed ID: 36116580 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy. Bazarbashi S; Alghabban A; Aseafan M; Aljubran AH; Alzahrani A; Elhassan TA World J Clin Cases; 2022 Mar; 10(8):2429-2438. PubMed ID: 35434075 [TBL] [Abstract][Full Text] [Related]
9. Significant Gene Biomarker Tyrosine Kinase Non-receptor 2 Mediated Cell Proliferation and Invasion in Colon Cancer. Ling S; He Y; Li X; Ma Y; Li Y; Kong B; Huang P Front Genet; 2021; 12():653657. PubMed ID: 34421982 [No Abstract] [Full Text] [Related]
10. Addition of bromelain and acetylcysteine to gemcitabine potentiates tumor inhibition Mekkawy AH; Pillai K; Badar S; Akhter J; Ke K; Valle SJ; Morris DL Am J Cancer Res; 2021; 11(5):2252-2263. PubMed ID: 34094682 [TBL] [Abstract][Full Text] [Related]
11. PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer. Raimondi L; Raimondi FM; Di Benedetto L; Cimino G; Spinelli GP Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962309 [TBL] [Abstract][Full Text] [Related]
12. Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer. Elshenawy MA; Badran A; Aljubran A; Alzahrani A; Rauf MS; Eldali A; Bazarbashi S World J Surg Oncol; 2020 Jul; 18(1):163. PubMed ID: 32641137 [TBL] [Abstract][Full Text] [Related]
13. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis. Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492 [No Abstract] [Full Text] [Related]
14. CK7 expression associates with the location, differentiation, lymph node metastasis, and the Dukes' stage of primary colorectal cancers. Fei F; Li C; Cao Y; Liu K; Du J; Gu Y; Wang X; Li Y; Zhang S J Cancer; 2019; 10(11):2510-2519. PubMed ID: 31258757 [No Abstract] [Full Text] [Related]
15. Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells. Krug S; Mordhorst JP; Moser F; Theuerkorn K; Ruffert C; Egidi M; Rinke A; Gress TM; Michl P PLoS One; 2019; 14(6):e0218953. PubMed ID: 31237925 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-loaded red blood cells reduced cardiac toxicity and preserved anticancer activity. Lucas A; Lam D; Cabrales P Drug Deliv; 2019 Dec; 26(1):433-442. PubMed ID: 30929538 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study. Aljubran A; Elshenawy MA; Kandil M; Zahir MN; Shaheen A; Gad A; Alshaer O; Alzahrani A; Eldali A; Bazarbashi S Clin Med Insights Oncol; 2019; 13():1179554918825447. PubMed ID: 30728734 [TBL] [Abstract][Full Text] [Related]
18. Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumab. Xu Y; Hay JW; Barzi A Cost Eff Resour Alloc; 2018; 16():30. PubMed ID: 30459532 [TBL] [Abstract][Full Text] [Related]
19. Identification of critical genes to predict recurrence and death in colon cancer: integrating gene expression and bioinformatics analysis. Long X; Deng Z; Li G; Wang Z Cancer Cell Int; 2018; 18():139. PubMed ID: 30237752 [TBL] [Abstract][Full Text] [Related]
20. Natural killer cells inhibit oxaliplatin-resistant colorectal cancer by repressing WBSCR22 via upregulating microRNA-146b-5p. Zhao H; Su W; Kang Q; Xing Z; Lin X; Wu Z Am J Cancer Res; 2018; 8(5):824-834. PubMed ID: 29888105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]